Cheryl Hendrickson to Anti-HIV Agents
This is a "connection" page, showing publications Cheryl Hendrickson has written about Anti-HIV Agents.
Connection Strength
1,919
-
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa: a retrospective cohort study. Lancet HIV. 2025 Feb; 12(2):e130-e142.
Score: 0,513
-
Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa. S Afr Med J. 2019 Aug 28; 109(9):679-685.
Score: 0,352
-
"My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa. J Int AIDS Soc. 2018 10; 21(10):e25184.
Score: 0,331
-
Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey. J Int AIDS Soc. 2024 Mar; 27(3):e26233.
Score: 0,120
-
Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa. BMC Public Health. 2023 08 15; 23(1):1553.
Score: 0,116
-
Initial implementation of PrEP in Zambia: health policy development and service delivery scale-up. BMJ Open. 2021 07 09; 11(7):e047017.
Score: 0,100
-
Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa. J Int AIDS Soc. 2021 02; 24(2):e25652.
Score: 0,097
-
Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study. BMJ Open. 2020 03 25; 10(3):e030228.
Score: 0,092
-
Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settings. Lancet HIV. 2020 04; 7(4):e294-e300.
Score: 0,091
-
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. J Int AIDS Soc. 2019 12; 22(12):e25427.
Score: 0,090
-
Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study. BMC Health Serv Res. 2017 Jan 17; 17(1):41.
Score: 0,018